<DOC>
	<DOCNO>NCT02379507</DOCNO>
	<brief_summary>This open-label , adaptive design study design determine efficacy study product treatment eczema would assess reduction appearance skin lesion symptom associate itching , scale redness .</brief_summary>
	<brief_title>DEC033 Study Product Mild Moderate Eczema An Open-label , Adaptive-design Pilot Study</brief_title>
	<detailed_description>Eczema inflammatory skin disease characterize itchy red rash commonly find elbow behind knee . Eczema lesion may appear collection fluid skin ( vesicle ) gross thicken skin ( lichenification ) redness . It also associate crusting , scaling , crack , swell skin . Usually , need medical treatment . However , severe form eczema refer atopic eczema atopic dermatitis occur childhood early adulthood . The overall prevalence condition Northern Europe 15-20 % child age 7-18 year . Atopic eczema greatly affect quality life individual fact account high score compare dermatological disease . A child eczema experience itch sleep disturbance , ostracism child , need special clothing bedding , avoidance physical activity swim need frequent application ointment . Eczema commonly treat antihistamine pill creams ointment . Antihistamines steroid cream control itch rash cause severe eczema . It also recommend skin well lubricated prevent become dry . A systematic review randomize clinical trial atopic eczema summarize intervention treat condition include pharmacological drug type ( topical steroid ) , similar intervention type ( dietary measure ) convenience ( non-pharmacological treatment ) . Shea butter , contain stearic acid , linoleic acid , catechin ( antioxidant ) , process nut Vitellaria paradoxa tree . It traditionally use lotion skin hair consider emollient skin conditioning agent . It also importance soothe arthritic pain , reduce swell , treat skin problem , antiseptic wound . Shea butter also find topical formulation use inflammatory dermatosis psoriasis atopic dermatitis . Shea butter consist triterpene cinnamates acetates found anti-inflammatory activity help reduction edema associate eczema . Human clinical study demonstrate shea butter skin age treatment regenerates skin give smoother , clear skin . Wrinkles photoaging also diminish . Another trial show shea butter cicatrize action 70 % case hand dermatitis , sun burn scar . A cream shea butter also demonstrate promote good moisturization skin compare placebo . Macadamia nut oil one heart-friendly oil . It contain vitamin E , omega-3 , omega-6 , oleic , linoleic , palmitoleic acid . Macadamia oil decrease low density lipoprotein level increase high density lipoprotein level thus reduce risk heart diseases . There various benefit macadamia oil skin . It provide moisturization anti-aging effect . Palmitoleic acid , commonly find skin , decrease people age . Macadamia oil help replace lose compound maintain youthful skin . Blemishes scar also remove help macadamia oil . It anti-inflammatory activity antioxidant effect thus reduce free radical skin provide heal skin condition sunburn . This open-label , adaptive design study design determine efficacy study product treatment eczema would assess reduction appearance skin lesion symptom associate itching , scale redness .</detailed_description>
	<mesh_term>Eczema</mesh_term>
	<criteria>Healthy male female ≥ 18 ≤ 70 year age . Body mass index ( BMI ) ≥ 20 ≤ 35 kg/m2 . Subjects mild moderate eczema ; determine screen visit . Judged Investigator general good health basis medical history . Agree use Studysupplied cleanser moisturizer body cosmetic apply irritated skin . Agree stop medication supplement entire length study Females child bear potential must agree use appropriate birth control method entire study period . Agree initiate new exercise diet program entire study period . Agree change current diet exercise program entire study period . Understands study procedure sign form provide informed consent participate study authorization release relevant protect health information study investigator . Clinically significant renal , hepatic , endocrine ( include diabetes mellitus ) , cardiac , pulmonary , pancreatic , neurologic , hematologic , biliary disorder . Known allergy sensitivity Herbal product . History presence cancer prior two year , include skin cancer suspicious lesion . Recent history alcoholism ( within 12 month ) strong potential alcohol substance abuse . Participation clinical study exposure nonregistered drug product within 30 day prior . Individual condition Investigator believe would interfere ability provide inform consent , comply study protocol , might confound interpretation study result put person undue risk . Including subject Bed wheelchairbound . Pregnant , lactating , unwilling use adequate contraception duration study . Smoking must nonsmoker least 12 week prior screen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>mild moderate</keyword>
</DOC>